0.10 (-%)
As of Oct 17, 2023
Source:
Athersys, Inc / New is a biotechnology company that is focused primarily in the field of regenerative medicine. Our MultiStem (invimestrocel) cell therapy, a patented and proprietary allogeneic stem cell product candidate, is our lead platform product and is currently in clinical development.
| Country | United States |
| Headquarters | cleveland, ohio |
| Phone Number | 216-431-9900 |
| Industry | manufacturing |
| CEO | Daniel A. Camardo |
| Website | www.athersys.com |